A new immunotherapy target for colorectal cancer
An international research team, led by scientists from Yale University, has identified a new immunotherapy target for treating colorectal cancer, developing an antibody that successfully reduces tumor formation in animal models. Though the antibody still needs to be tested in humans, it could eventually be used as a new immunotherapy inhibitor to treat colorectal and